Bromocriptine Versus Levodopa and other treatments in Parkinson’s Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials
Maziar Afshar, Negin Sane, Yousef Moradi. Bromocriptine Versus Levodopa and other treatments in Parkinson’s Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials. // Acta Neurologica Belgica. – 2024. – DOI: 10.1007/s13760-024-02711-w. – URL: https://doi.org/10.1007/s13760-024-02711-w
Maziar Afshar, Negin Sane, & Yousef Moradi (2024). Bromocriptine Versus Levodopa and other treatments in Parkinson’s Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-024-02711-w
Maziar Afshar, et al. “Bromocriptine Versus Levodopa and other treatments in Parkinson’s Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials.” Acta Neurologica Belgica, 2024. doi:10.1007/s13760-024-02711-w.
@article{Afshar2024,
title = {Bromocriptine Versus Levodopa and other treatments in Parkinson’s Disease: an updated Meta-analysis Involving more than 4000 patients across 12 randomized clinical trials},
author = {Afshar, Maziar and Sane, Negin and Moradi, Yousef},
journal = {Acta Neurologica Belgica},
year = {2024},
doi = {10.1007/s13760-024-02711-w},
url = {https://doi.org/10.1007/s13760-024-02711-w}
}